Bill Summary & Status
112th Congress (2011 - 2012)
S.AMDT.2111
NEW SEARCH | HOME | HELP
S.AMDT.2111
Amends: S.3187
Sponsor: Sen Bingaman, Jeff [NM] (submitted 5/17/2012) (proposed 5/24/2012)
AMENDMENT PURPOSE:
To provide substantial savings in health care costs to the Federal government and consumers by fostering competition among generic pharmaceutical manufacturers and ensuring that anti-competitive "pay-for-delay" settlements between brand-name and generic pharmaceutical manufacturers do not block generic drugs from entering the market.
TEXT OF AMENDMENT AS SUBMITTED: CR S3290-3291
STATUS:
- 5/24/2012:
- Amendment SA 2111 proposed by Senator Bingaman. (consideration: CR S3542-3543, S3547-3548, S3553-3554)
- 5/24/2012:
- Amendment SA 2111, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 28 - 67. Record Vote Number: 105.
COSPONSORS(10):
Sen Vitter, David [LA]
- 5/17/2012
Sen Franken, Al [MN]
- 5/17/2012
Sen Shaheen, Jeanne [NH]
- 5/17/2012
Sen Kohl, Herb [WI]
- 5/17/2012
Sen Udall, Tom [NM]
- 5/17/2012
Sen Johnson, Tim [SD]
- 5/17/2012
Sen Klobuchar, Amy [MN]
- 5/17/2012
Sen Merkley, Jeff [OR]
- 5/17/2012
Sen Sanders, Bernard [VT]
- 5/17/2012
Sen Brown, Sherrod [OH]
- 5/21/2012
